These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern -A hospital based cross sectional study. Fernando MM; Luke WA; Miththinda JK; Wickramasinghe RD; Sebastiampillai BS; Gunathilake MP; Silva FH; Premaratna R BMC Infect Dis; 2017 Feb; 17(1):138. PubMed ID: 28187754 [TBL] [Abstract][Full Text] [Related]
4. Risk factors for community acquired pediatric urinary tract infection with extended-spectrum-β-lactamase Escherichia coli - A case-control study. Collingwood JD; Wang L; Aban IB; Yarbrough AH; Boppana SB; Dangle PP J Pediatr Urol; 2023 Feb; 19(1):129.e1-129.e7. PubMed ID: 36344365 [TBL] [Abstract][Full Text] [Related]
5. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials. Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039 [TBL] [Abstract][Full Text] [Related]
6. Risk factors for community-onset urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli. Tüzün T; Sayın Kutlu S; Kutlu M; Kaleli İ Turk J Med Sci; 2019 Aug; 49(4):1206-1211. PubMed ID: 31385490 [TBL] [Abstract][Full Text] [Related]
7. Prevalence, antibiotic sensitivity pattern and genetic analysis of extended spectrum beta lactamase producing Escherichia coli and Klebsiella spp among patients with community acquired urinary tract infection in Galle district, Sri Lanka. Priyadharshana U; Piyasiri LB; Wijesinghe C Ceylon Med J; 2019 Dec; 64(4):140-145. PubMed ID: 32120467 [TBL] [Abstract][Full Text] [Related]
8. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721 [TBL] [Abstract][Full Text] [Related]
9. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children. Fan NC; Chen HH; Chen CL; Ou LS; Lin TY; Tsai MH; Chiu CH J Microbiol Immunol Infect; 2014 Oct; 47(5):399-405. PubMed ID: 23834784 [TBL] [Abstract][Full Text] [Related]
11. Community-onset extended-spectrum β-lactamase producing Escherichia coli in urinary tract infections in children from 2015 to 2016: Prevalence, risk factors, and resistances. Pérez Heras I; Sanchez-Gomez JC; Beneyto-Martin P; Ruano-de-Pablo L; Losada-Pinedo B Medicine (Baltimore); 2017 Dec; 96(50):e8571. PubMed ID: 29390257 [TBL] [Abstract][Full Text] [Related]
12. Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities. Saltoglu N; Karali R; Yemisen M; Ozaras R; Balkan II; Mete B; Tabak F; Mert A; Hondur N; Ozturk R Int J Clin Pract; 2015 Jul; 69(7):766-70. PubMed ID: 25683907 [TBL] [Abstract][Full Text] [Related]
13. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common. Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462 [TBL] [Abstract][Full Text] [Related]
14. Risk factors for community acquired urinary tract infections caused by extended spectrum β-lactamase (ESBL) producing Zhu FH; Rodado MP; Asmar BI; Salimnia H; Thomas R; Abdel-Haq N Infect Dis (Lond); 2019; 51(11-12):802-809. PubMed ID: 31429616 [No Abstract] [Full Text] [Related]
15. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin. Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972 [TBL] [Abstract][Full Text] [Related]